Delisting risk
Senti Biosciences
Gene-circuit developer for programmable cell and gene therapies.
$0.3946
After-hours close+0.02 (+6.08%)
At close$0.3720(−1.46%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.21 | — | — |
| Aug 2026 | −$0.33 | −$0.41 | −24.2% |
| May 2026 | −$0.27 | −$0.36 | −33.3% |
| Mar 2026 | −$0.43 | −$0.38 | +11.6% |
| Nov 2025 | −$0.59 | −$0.69 | −16.9% |
The latest year is open to everyone — the 19 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Aug 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jul 2021 | |||
| Dec 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.21 | — | — | $15.9K | — | — |
| Aug 14, 2026 | −$0.33 | −$0.41 | −24.2% | $17.0K | $17.0K | 0.0% |
| May 14, 2026 | −$0.27 | −$0.36 | −33.3% | $16.0K | $16.0K | 0.0% |
| Mar 27, 2026 | −$0.43 | −$0.38 | +11.6% | $1.0M | $22.0K | −97.8% |
| Nov 13, 2025 | −$0.59 | −$0.69 | −16.9% | $250.0K | — | — |
The latest year is open to everyone — the 19 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 6, 2025 | ||||||
| Mar 20, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 13, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 21, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 11, 2023 | ||||||
| May 9, 2023 | ||||||
| Mar 22, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 15, 2022 | ||||||
| Aug 9, 2022 | ||||||
| Mar 7, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 6, 2021 | ||||||
| Jul 2, 2021 | ||||||
| Dec 31, 2020 | ||||||